![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 239/54 | |
A61K 31/522 | |||
A61P 31/14 | |||
B01J 31/24 | |||
A61K 31/7056 | |||
A61K 31/513 | |||
A61K 45/06 | |||
A61K 38/21 |
(11) | Patento numeris | 3056486 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16158981.7 |
Europos patento paraiškos padavimo data | 2011-07-15 | |
(97) | Europos patento paraiškos paskelbimo data | 2016-08-17 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-11 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
365293 P | 2010-07-16 | US | |
201161444475 P | 2011-02-18 | US |
(72) |
SHEKHAR, Shashank, US
FRANCZYK, Thaddeus S., US
BARNES, David M., US
DUNN, Travis B., US
HAIGHT, Anthony R., US
CHAN, Vincent S., US
|
(73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
(54) | PROCESS FOR PREPARING INTERMEDIATES FOR ANTIVIRAL COMPOUNDS |
PROCESS FOR PREPARING INTERMEDIATES FOR ANTIVIRAL COMPOUNDS |